Ranolazine dihydrochloride structure
|
Common Name | Ranolazine dihydrochloride | ||
---|---|---|---|---|
CAS Number | 95635-56-6 | Molecular Weight | 500.458 | |
Density | N/A | Boiling Point | 624.1ºC at 760 mmHg | |
Molecular Formula | C24H35Cl2N3O4 | Melting Point | 222-229.5ºC(lit.) | |
MSDS | Chinese USA | Flash Point | N/A |
Use of Ranolazine dihydrochlorideRanolazine(RS-43285) is an antianginal agent with antiarrhythmic properties that achieves its effects via a novel mechanism of action (inhibition of the late phase of the inward sodium current), without affecting heart rate or blood pressure (BP). IC50 value:Target: sodium-dependent calcium channelRanolazine is currently approved for use in chronic angina. The basis for this use is likely related to inhibition of late sodium channels with resultant beneficial downstream effects. Randomized clinical trials have demonstrated an improvement in exercise capacity and reduction in angina episodes with ranolazine. |
Name | Ranolazine dihydrochloride |
---|---|
Synonym | More Synonyms |
Description | Ranolazine(RS-43285) is an antianginal agent with antiarrhythmic properties that achieves its effects via a novel mechanism of action (inhibition of the late phase of the inward sodium current), without affecting heart rate or blood pressure (BP). IC50 value:Target: sodium-dependent calcium channelRanolazine is currently approved for use in chronic angina. The basis for this use is likely related to inhibition of late sodium channels with resultant beneficial downstream effects. Randomized clinical trials have demonstrated an improvement in exercise capacity and reduction in angina episodes with ranolazine. |
---|---|
Related Catalog | |
References |
Boiling Point | 624.1ºC at 760 mmHg |
---|---|
Melting Point | 222-229.5ºC(lit.) |
Molecular Formula | C24H35Cl2N3O4 |
Molecular Weight | 500.458 |
Exact Mass | 499.200470 |
PSA | 74.27000 |
LogP | 3.86080 |
Appearance of Characters | solid | off-white |
Storage condition | Desiccate at RT |
Water Solubility | H2O: 10 mg/mL, soluble |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Safety Phrases | S22-S24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 2942000000 |
HS Code | 2942000000 |
---|
Regulation of Hyaluronan (HA) Metabolism Mediated by HYBID (Hyaluronan-binding Protein Involved in HA Depolymerization, KIAA1199) and HA Synthases in Growth Factor-stimulated Fibroblasts.
J. Biol. Chem. 290 , 30910-23, (2015) Regulation of hyaluronan (HA) synthesis and degradation is essential to maintenance of extracellular matrix homeostasis. We recently reported that HYBID (HYaluronan-Binding protein Involved in hyaluro... |
Ranolazine dihydrochloride |
RANOLAZINE HCL |
MFCD03788770 |
RANOLAZINE DI HCL |
Ranolazine (dihydrochloride) |
N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazinyl}acetamide dihydrochloride |
Ranolazine DiHCI |
Ranolazine and salt |
1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, hydrochloride (1:2) |
Ranolazine Dihydrocloride |
Ranolazine 2HCl |
N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide dihydrochloride |
Ranolazine dihydroch |